1. Panels
  2. Childhood solid tumours cancer susceptibility
  3. TRIP13
STRs in panel
Prev Next
Regions in panel
Prev Next

Childhood solid tumours cancer susceptibility

Gene: TRIP13

Green List (high evidence)
TRIP13 (thyroid hormone receptor interactor 13)
EnsemblGeneIds (GRCh38): ENSG00000071539
EnsemblGeneIds (GRCh37): ENSG00000071539
OMIM: 604507, Gene2Phenotype
TRIP13 is in 7 panels

1 review

Zornitza Stark (Australian Genomics)

Green List (high evidence)

Predisposition to Wilms tumour, six unrelated individuals reported.
Created: 1 Aug 2020, 8:17 a.m. | Last Modified: 1 Aug 2020, 8:18 a.m.
Panel Version: 1.6

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Mosaic variegated aneuploidy syndrome 3, MIM# 617598

Publications

Created: 1 Aug 2020, 8:17 a.m.
Last Modified: 1 Aug 2020, 8:18 a.m.
Panel version: 1.6

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Green
Phenotypes
  • Mosaic variegated aneuploidy syndrome 3 617598
OMIM
604507
Clinvar variants
Variants in TRIP13
Penetrance
None
Panels with this gene

History Filter Activity

5 Aug 2020, Gel status: 3

Entity classified by Genomics England curator

Arina Puzriakova (Genomics England Curator)

Gene: trip13 has been classified as Green List (High Evidence).

26 Mar 2019, Gel status: 2

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Ellen McDonagh (Genomics England Curator)

gene: TRIP13 was added gene: TRIP13 was added to Childhood solid tumours pertinent cancer susceptibility. Sources: Expert Review Amber Mode of inheritance for gene: TRIP13 was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: TRIP13 were set to Mosaic variegated aneuploidy syndrome 3 617598